Table:
begin	end	state
1	5	non-cytoplasmic
6	25	transmembrane
26	45	cytoplasmic
46	68	transmembrane
69	73	non-cytoplasmic
74	92	transmembrane
93	115	cytoplasmic
116	138	transmembrane
139	145	non-cytoplasmic
146	170	transmembrane
171	178	cytoplasmic
179	200	transmembrane
201	233	non-cytoplasmic
234	256	transmembrane
257	267	cytoplasmic
268	293	transmembrane
294	325	non-cytoplasmic
326	354	transmembrane
355	374	cytoplasmic
375	394	transmembrane
395	399	non-cytoplasmic
400	422	transmembrane
423	431	cytoplasmic
432	455	transmembrane
456	466	non-cytoplasmic
467	488	transmembrane
489	520	cytoplasmic

Input:
>PP_3272
MNWTAISMFMVFVCFTLLVTRWAALRTRSASDFYTAGGGLTGMQNGLAIAGDMISAASFL
GISAMMFMNGYDGLLYALGVLAGWPIILFLIAERLRNLGKYTFADVVSYRLAQTPVRLTS
AFGTLVVALMYLVAQMVGAGKLIELLFGISYLYAVMLVGVLMVSYVTFGGMLATTWVQII
KAVMLLSGTSFMAFMVLKHFGFSTEAMFASAVAVHAKGQAIMAPGGLLSNPVDAISLGLG
MMFGTAGLPHILMRFFTVSDAKEARKSVFYATGFIGYFYLLLIVVGFGAIVMVGTEPSYR
DATGAIIGGGNMVAVHLAQAVGGNLFLGFISAVAFATILAVVAGLALSGASAVSHDLYAC
VMRKGKATEQEEMRVSRIATLLIGLLAVILGLMFESQNIAFLSGLVLAVAASVNFPVLLL
SMFWKGLTTRGAVCGSMAGLVSAVLLVVLGPAVWVNVLHNETALFPYSNPALFSMSLAFL
SAWVFSVTDTSERAVEERGRYLGQFIRSMTGIGAAGASKH

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server